Price
CHART BY
Frequently asked questions
What is Wuxi Biologics Cayman ADR's market capitalization?
The market capitalization of Wuxi Biologics Cayman ADR is 17.23B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Wuxi Biologics Cayman ADR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Wuxi Biologics Cayman ADR is 29.18. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Wuxi Biologics Cayman ADR?
Wuxi Biologics Cayman ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.286. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Wuxi Biologics Cayman ADR's stock?
Currently, 13 analysts cover Wuxi Biologics Cayman ADR's stock, with a consensus target price of 10.91. Analyst ratings provide insights into the stock's expected performance.
What is Wuxi Biologics Cayman ADR's revenue over the trailing twelve months?
Over the trailing twelve months, Wuxi Biologics Cayman ADR reported a revenue of 2.78B.
What is the EBITDA for Wuxi Biologics Cayman ADR?
Wuxi Biologics Cayman ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 1.00B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Wuxi Biologics Cayman ADR?
Wuxi Biologics Cayman ADR has a free cash flow of 276.47M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Wuxi Biologics Cayman ADR have, and what sector and industry does it belong to?
Wuxi Biologics Cayman ADR employs approximately 12,575 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
Financials
- Market Cap
- 17.23B
- EPS (TTM)
- $0.286
- P/E ratio (TTM)
- 29.18
- Revenue (TTM)
- 2.78B
- EBITDA (TTM)
- 1.00B
- Free Cashflow (TTM)
- 276.47M
Pricing
- 1D span
- $8.393$8.826
- 52W span
- $4.034$10.73
Analyst Ratings
The price target is 10.91 and the stock is covered by 13 analysts.
Buy
12
Hold
1
Sell
0
Information
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
- Employees
- 12,575
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- WXXWY
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet